Učitavanje...

The PPARγ Agonist Pioglitazone Ameliorates Aging-Related Progressive Renal Injury

Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists not only improve metabolic abnormalities of diabetes and consequent diabetic nephropathy, but they also protect against nondiabetic chronic kidney disease in experimental models. Here, we found that the PPAR-γ agonist pioglitazone protec...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Yang, Hai-Chun, Deleuze, Sebastien, Zuo, Yiqin, Potthoff, Sebastian A., Ma, Li-Jun, Fogo, Agnes B.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Nephrology 2009
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2799181/
https://ncbi.nlm.nih.gov/pubmed/19797472
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2008111138
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!